BUENA, N.J., April 22, 2014 /PRNewswire/ -- IGI
Laboratories, Inc. (NYSE MKT: IG), a New
Jersey based topical generic drug development and
manufacturing company, announced the Company will hold a conference
call at 4:30 pm ET on Tuesday, April 29, 2014 to discuss the 1st
quarter 2014 results.
The Company invites you to listen to the call by dialing
1-866-515-2913. International participants should call
1-617-399-5127. The passcode for the conference call is
66700649.
This call is being webcast by NASDAQ OMX and can be accessed at
IGI's website at www.igilabs.com.
The webcast is also being distributed through third party
distribution channels, including the StreetEvents Network operated
by Thomson Reuters (Markets) LLC and its affiliates.
About IGI Laboratories, Inc.
IGI Laboratories is a generic topical pharmaceutical
company. We develop and manufacture topical formulations for
the pharmaceutical, OTC, and cosmetic markets. Our mission is to be
a leading player in the generic topical prescription drug
market.
Logo -
http://photos.prnewswire.com/prnh/20130827/MM70487LOGO
SOURCE IGI Laboratories, Inc.